研究実績  |  RESULTS ACHIEVEMENT

英文論文

    2018
  • Katanoda K, Noda M, Goto A, Mizunuma H, Lee JS, Hayashi K: Being underweight in adolescence is independently associated with adult-onset diabetes among women: The Japan Nurses’ Health Study. J Diabetes Investig ,2018

  • 2017
  • Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ishizuka N, Ohashi Y, Noda M, Kadowaki T: Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet Diabetes Endocrinol 5:951-964,2017

  • 2017
  • Awata T, Shimada A, Maruyama T, Oikawa Y, Yasukawa N, Kurihara S, Miyashita Y, Hatano M, Ikegami Y, Matsuda M, Niwa M, Kazama Y, Tanaka S, Kobayashi T: Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S). Diabetes Ther 8:1123-1134,2017

  • 2017
  • Ito D, Shimizu S, Inoue K, Saito D, Yanagisawa M, Inukai K, Akiyama Y, Morimoto Y, Noda M, Shimada A: Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial. Diabetes Care 40:1364-1372,2017

  • 2017
  • Kabeya Y, Uchida J, Toyoda M, Katsuki T, Oikawa Y, Kato K, Kawai T, Shimada A, Atsumi Y, Higaki M: Factors affecting consultation length in a Japanese diabetes practice. Diabetes Res Clin Pract 126:54-59,2017

  • 2017
  • Ito D, Ikuma-Suwa E, Inoue K, Kaneko K, Yanagisawa M, Inukai K, Noda M, Shimada A: Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients with Type 2 Diabetes: An Open-Label Study. J Clin Med Res 9:154-162,2017

  • 2017
  • Teramoto Y, Nakamura Y, Asami Y, Imamura T, Takahira S, Nemoto M, Sakai G, Shimada A, Noda M, Yamamoto A: Case of type 1 diabetes associated with less-dose nivolumab therapy in a melanoma patient. J Dermatol 2017;44(5):605-606.

  • 2017
  • Kanamori K, Ihana-Sugiyama N, Yamamoto-Honda R, Nakamura T, Sobe C, Kamiya S, Kishimoto M, Kajio H, Kawano K, Noda M: Postprandial Glucose Surges after Extremely Low Carbohydrate Diet in Healthy Adults. Tohoku J Exp Med 243:35-39,2017

  • 2017
  • Ideno Y, Hayashi K, Abe Y, Ueda K, Iso H, Noda M, Lee JS, Suzuki S: Blood pressure-lowering effect of Shinrin-yoku (Forest bathing): a systematic review and meta-analysis. BMC Complement Altern Med 17:409,2017

  • 2017
  • Imai H, Furukawa TA, Hayashi SU, Goto A, Izumi K, Hayashino Y, Noda M: Risk perception, self-efficacy, trust for physician, depression, and behavior modification in diabetic patients. J Health Psychol 1359105317718057,2017

  • 2017
  • Katanoda K, Noda M, Goto A, Mizunuma H, Lee JS, Hayashi K: Impact of birth weight on adult-onset diabetes mellitus in relation to current body mass index: The Japan Nurses’ Health Study. J Epidemiol 27:428-434,2017

  • 2017
  • Akter S, Kurotani K, Sato M, Hayashi T, Kuwahara K, Matsushita Y, Nakagawa T, Konishi M, Honda T, Yamamoto S, Hayashi T, Noda M, Mizoue T: High Serum Phospholipid Dihomo-gamma-Linoleic Acid Concentration and Low Delta5-Desaturase Activity Are Associated with Increased Risk of Type 2 Diabetes among Japanese Adults in the Hitachi Health Study. J Nutr 147:1558-1566,2017

  • 2017
  • Tsujimoto T, Sugiyama T, Shapiro MF, Noda M, Kajio H: Risk of Cardiovascular Events in Patients with Diabetes Mellitus on beta-Blockers. Hypertension 70:103-110,2017

  • 2017
  • Akter S, Nanri A, Mizoue T, Noda M, Sawada N, Sasazuki S, Tsugane S: Dietary acid load and mortality among Japanese men and women: the Japan Public Health Center-based Prospective Study. Am J Clin Nutr 106:146-154,2017

  • 2017
  • Nanri A, Mizoue T, Shimazu T, Ishihara J, Takachi R, Noda M, Iso H, Sasazuki S, Sawada N, Tsugane S: Dietary patterns and all-cause, cancer, and cardiovascular disease mortality in Japanese men and women: The Japan public health center-based prospective study. PLoS One 12:e0174848,2017

  • 2017
  • Goto A, Noda M, Goto M, Yasuda K, Mizoue T, Yamaji T, Sawada N, Iwasaki M, Inoue M, Tsugane S: Plasma adiponectin levels, ADIPOQ variants, and incidence of type 2 diabetes: A nested case-control study. Diabetes Res Clin Pract 127:254-264,2017

  • 2017
  • Ikeda N, Nishi N, Noda H, Noda M: Trends in prevalence and management of diabetes and related vascular risks in Japanese adults: Japan National Health and Nutrition Surveys 2003-2012. Diabetes Res Clin Pract 127:115-122,2017

  • 2017
  • Yamamoto-Honda R, Takahashi Y, Mori Y, Yamashita S, Yoshida Y, Kawazu S, Iwamoto Y, Kajio H, Yanai H, Mishima S, Handa N, Shimokawa K, Yoshida A, Watanabe H, Ohe K, Shimbo T, Noda M: A positive family history of hypertension might be associated with an accelerated onset of type 2 diabetes: Results from the National Center Diabetes Database (NCDD-02). Endocr J 64:515-520,2017

  • 2017
  • Ihana-Sugiyama N, Yamamoto-Honda R, Sugiyama T, Tsujimoto T, Kakei M, Noda M: Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus. Med Sci Monit Basic Res 23:36-44,2017

  • 2017
  • Akter S, Nanri A, Kuwahara K, Matsushita Y, Nakagawa T, Konishi M, Honda T, Yamamoto S, Hayashi T, Noda M, Mizoue T: Circulating ferritin concentrations and risk of type 2 diabetes in Japanese individuals. J Diabetes Investig 8:462-470,2017

  • 2017
  • Takahashi E, Unoki-Kubota H, Shimizu Y, Okamura T, Iwata W, Kajio H, Yamamoto-Honda R, Shiga T, Yamashita S, Tobe K, Okumura A, Matsumoto M, Yasuda K, Noda M, Kaburagi Y: Proteomic analysis of serum biomarkers for prediabetes using the Long-Evans Agouti rat, a spontaneous animal model of type 2 diabetes mellitus. J Diabetes Investig 8:661-671,2017

  • 2017
  • Oikawa Y, Shimada A, Awata T, Fukui T, Ikegami H, Imagawa A, Kajio H, kawabata Y, kawasaki E, Miura j, Osawa H, Takahashi K, Tanaka S, Uchigata Y, Yasuda H, Yasuda K, Hanafusa T, Kobayashi T, Research Committee on Type 1 Diabetes of the Japan Diabetes Society: Clinical features of cases of seroconversion of anti-glutamic acid decarboxylase antibody during the clinical course of type 2 diabetes: a nationwide survey in Japan. Diabetol Int 8:306-315,2017

  • 2017
  • Satoh H, Ohira T, Moriya C, Inoue I, Kuribayashi S, Seino H, Hirai H, Hiyoshi T, Watada H: Effects of linagliptin vs. voglibose on daily glucose excursions during continuous glucose monitoring of Japanese type 2 diabetes patients (L-CGM): A randomized, open-label, two-arm, parallel comparative trial. Diabetes Metab 43:550-553,2017

  • 2017
  • Inoue I, Kubota R, Yanagi S, Akita M, Nakano T, Katayama S, Shimada A, Noda M. The new molecular entity evolocumab, one kind of PCSK9 inhibitor, reduce plasma small size LDL-cholesterol levels by using a new standardized method of measuring LDL size. Open Journal of Molecular and Integrative Physiology 7:1-23, 2017 

  • 2017
  • Sakai G, Inoue I, Suzuki T, Sumita T, Inukai K, Katayama S, Awata T, Yamada T, Asano T, Katagiri H, Noda M, Shimada A, Ono H. Effects of the activations of three major hepatic Akt substrates on glucose metabolism in male mice. Endocrinology 158:2659-2671, 2017 

  • 2017
  • Oikawa Y, Tanaka H, Uchida J, Atsumi Y, Osawa M, Katsuki T, Kawai T, Shimada A. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state. Endocr J. 2017;64(2):163-170.

  • 2016
  • Pancreatic ductal hyperplasia/dysplasia with obstructive chronic pancreatitis: an association with reduced pancreatic weight in type 1 diabetes. Diabetologia. 2016 ;59(4):865-7.
  • 2016
  • Shimada A. Autoimmunity as an etiology of fulminant type 1 diabetes. Diabetol Int (2016) 7:104-5.

  • 2016
  • Yasui J, Kawasaki E, Tanaka S, Awata T, Ikegami H, Imagawa A, Uchigata Y, Osawa H, Kajio H, Kawabata Y, Shimada A, Takahashi K, Yasuda K, Yasuda H, Hanafusa T, Kobayashi T; Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research. Clinical and Genetic Characteristics of Non-Insulin- Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan. PLoS One. 2016 ;11(5):e0155643.
  • 2016
  • Tomita M, Kabeya Y, Okisugi M, Katsuki T, Oikawa Y, Atsumi Y, Matsuoka K,Shimada A. Diabetic Microangiopathy Is an Independent Predictor of Incident Diabetic Foot Ulcer. J Diabetes Res. 2016;2016:5938540.
  • 2016
  • Ueki K, Sasako T, Kato M, Okazaki Y, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ohashi Y, Noda M, Kadowaki T, and the J-DOIT3 Study Group: Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial. BMJ Open Diabetes Res Care 4(1) Jan 25:e000123, 2016.

ACCESSご案内

埼玉医科大学

埼玉医科大学病院

〒350-0495 埼玉県入間郡毛呂山町毛呂本郷38
TEL: 049-276-1111(代)
FAX: 049-294-9752

お車をご利用される方
鶴ヶ島インターから約10km(約20~30分)
詳しくはこちら

電車・バスをご利用される方
池袋駅より東毛呂駅まで約1時間
東毛呂駅からバス(約5分)もしくは徒歩(約20分)
詳しくはこちら

本フォームは医療従事者専用となっております。ご病状やお薬、検査、予約など診療に関する患者さんからのご相談は、法律上、一切お受けすることができません。ご理解のほどよろしくお願いいたします。